122 related articles for article (PubMed ID: 22293276)
1. Low serum sex hormone-binding globulin: marker of inflammation?
Liao CH; Li HY; Yu HJ; Chiang HS; Lin MS; Hua CH; Ma WY
Clin Chim Acta; 2012 Apr; 413(7-8):803-7. PubMed ID: 22293276
[TBL] [Abstract][Full Text] [Related]
2. Relation between androgens and cardiovascular risk factors in a young population.
Gannagé-Yared MH; Chedid R; Abs L
Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
[TBL] [Abstract][Full Text] [Related]
3. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
4. Testosterone and sex hormone-binding globulin have significant association with metabolic syndrome in Taiwanese men.
Liao CH; Huang CY; Li HY; Yu HJ; Chiang HS; Liu CK
Aging Male; 2012 Mar; 15(1):1-6. PubMed ID: 22091971
[TBL] [Abstract][Full Text] [Related]
5. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations.
Yasui T; Tomita J; Miyatani Y; Yamada M; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
Clin Chim Acta; 2007; 386(1-2):69-75. PubMed ID: 17825805
[TBL] [Abstract][Full Text] [Related]
6. Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women.
Yasui T; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
Clin Chim Acta; 2008 Dec; 398(1-2):43-7. PubMed ID: 18755173
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
[TBL] [Abstract][Full Text] [Related]
8. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women.
Maturana MA; Moreira RM; Spritzer PM
Maturitas; 2011 Dec; 70(4):395-9. PubMed ID: 22018728
[TBL] [Abstract][Full Text] [Related]
9. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
10. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
[TBL] [Abstract][Full Text] [Related]
11. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women.
Sunbul M; Eren F; Nacar C; Agirbasli M
Cardiol J; 2013; 20(3):287-93. PubMed ID: 23788303
[TBL] [Abstract][Full Text] [Related]
14. Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men.
Nakhai Pour HR; Grobbee DE; Muller M; van der Schouw YT
Clin Endocrinol (Oxf); 2007 Mar; 66(3):394-8. PubMed ID: 17302874
[TBL] [Abstract][Full Text] [Related]
15. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
Noyan V; Yucel A; Sagsoz N
Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
[TBL] [Abstract][Full Text] [Related]
17. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
18. Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with Type 2 diabetes mellitus.
Laing I; Olukoga AO; Gordon C; Boulton AJ
Diabet Med; 1998 Jun; 15(6):473-9. PubMed ID: 9632121
[TBL] [Abstract][Full Text] [Related]
19. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Onat A; Hergenç G; Can G; Küçükdurmaz Z
Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
[TBL] [Abstract][Full Text] [Related]
20. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.
Haring R; Völzke H; Spielhagen C; Nauck M; Wallaschofski H
Eur J Prev Cardiol; 2013 Dec; 20(6):1061-8. PubMed ID: 22711969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
